The hidden cost of genetic resistance to HIV-1

被引：0

作者：

Jeremy Luban

机构：

[1] University of Massachusetts Medical School,Program in Molecular Medicine

[2] University of Massachusetts Medical School,Department of Biochemistry and Molecular Pharmacology

来源：

Nature Medicine | 2019年 / 25卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Assessment of more than 400,000 people over the age of 40 demonstrates that homozygosity for a CCR5 variant that prevents HIV-1 infection comes at the cost of increased rates of mortality.

引用

页码：878 / 879

页数：1

共 50 条

[41] Significance of HIV-1 genetic subtypes
Alaeus, A
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2000, 32 (05) : 455 - 463
[42] HIV-1 Entry, Inhibitors, and Resistance
Lobritz, Michael A.
Ratcliff, Annette N.
Arts, Eric J.
VIRUSES-BASEL, 2010, 2 (05): : 1069 - 1105
[43] Antiretroviral drug resistance in HIV-1
George J. Hanna
Richard T. D’Aquila
Current Infectious Disease Reports, 1999, 1 (3) : 289 - 297
[44] Testing for HIV-1 drug resistance
Hanna, GJ
Caliendo, AM
MOLECULAR DIAGNOSIS, 2001, 6 (04): : 253 - 263
[45] Clinical management of HIV-1 resistance
Paredes, Roger
Clotet, Bonaventura
ANTIVIRAL RESEARCH, 2010, 85 (01) : 245 - 265
[46] An update on HIV-1 antiretroviral resistance
Plank, Rebeca M.
Kuritzkes, Daniel R.
CURRENT OPINION IN HIV AND AIDS, 2006, 1 (05) : 417 - 423
[47] Detection of antiretroviral resistance in HIV-1
Cavert, W
Balfour, HH
CLINICS IN LABORATORY MEDICINE, 2003, 23 (04) : 915 - +
[48] Mechanisms of HIV-1 drug resistance
Larder, B
AIDS, 2001, 15 : S27 - S34
[49] Understanding HIV-1 drug resistance
Frenkel, LM
Tobin, NH
THERAPEUTIC DRUG MONITORING, 2004, 26 (02) : 116 - 121
[50] Transmission of HIV-1 drug resistance
Tang, JW
Pillay, D
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (01) : 1 - 10

← 1 2 3 4 5 →